From: VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Parameter | HR (95% C.I.) | P value | HR (95% C.I.) | P value |
VRK2 expression | 1.80 (1.07 – 3.02) | 0.025 | 2.10 (1.24 – 3.58) | 0.006 |
Age (<60 vs. ≥ 60) | 1.94 (1.15 – 3.26) | 0.011 | 1.80 (1.06 – 3.05) | 0.031 |
Treatment (Chemo + RT vs. RT alone vs. no treatment) | 1.96 (1.22 – 3.15) | 0.003 | 2.01 (1.22 – 3.30) | 0.006 |